MMI Co-Founder, John Hipp, PhD. to be Guest Editor for Special Issue of Bioengineering! Submit by Nov 30!
Press Release!: Driving Excellence in Cardiovascular Trials: MMI and Healthcare Inroads Deepen Collaboration
Insights from the 2022 OARSI Clinical Trials Symposium
In a research letter in Spine, MMI collaborated with researchers to investigate the SPSI as an objective measure of instability in lumbar stenosis patients with degenerative spondylolisthesis.
MMI is proud to have partnered with Moximed on an FDA-regulated IDE study to investigate the safety and effectiveness of the MISHA Knee System as a treatment option for younger patients with mild to moderate OA.
Semi-automated quantitative measurements of sinus inflammation from 3D CT imaging correlate well with clinical outcomes.
Facing an aging population and unprecedented scrutiny over treatment costs, clinical trials that seek to improve treatment of late-stage conditions and diseases such as osteoarthritis are set to make a significant impact.
A new study finds that small brain lesions previously thought to be insignificant are associated with heightened risk of stroke, increasing the importance of utilizing the very best medical imaging technology and experienced readers.
Total shoulder arthroplasty (TSA) is becoming increasingly more common as a treatment for disabling pain or impaired shoulder function. Dr. Jonelle Petscavage, a Medical Metrics’ (MMI) consultant, recently published a two-part review in the American Journal of Roentgenology on the current state-of-the-art in shoulder arthroplasty. Covering topics such as epidemiology, history, preoperative imaging, hemiarthroplasty, anatomic …
